Evaluation of ADH4 gene expression and hematological parameters as biomarkers for the pathogenesis of ITP in the pediatric

This study investigates the role of the ADH4 gene expression and hematological biomarkers in the pathogenesis of Immune Thrombocytopenic Purpura (ITP) in pediatric patients. The study involved 100 children, 50 with ITP and 50 healthy controls, to evaluate blood parameters and ADH4 gene expression. Results showed the mean white blood cell (WBC) count was significantly lower in ITP patients (8.11 ± 0.73) compared to controls (11.94 ± 0.69), Similarly, lymphocyte counts were significantly reduced in ITP patients (3.29 ± 0.43) versus controls (5.65 ± 0.42), The platelet count was markedly lower in ITP patients (26.18 ± 2.77) compared to controls (277.40 ± 10.74), On the contrary, The results show there was a non-significant difference between ITP patients and healthy individuals according to both neutrophil count and hemoglobin (Hb) levels (P < 0.05), while, ADH4 gene expression was significantly higher in ITP patients shown The mean 13.29, 1.00 between the ITP patients and Control respectively, suggesting its involvement in immune dysregulation. These findings highlight the potential of the ADH4 gene and some hematological parameter as a biomarker and therapeutic target in ITP, emphasizing the need for personalized treatment approaches